Rileen Sinha

39.9k citations

18 papers · 13.2k indexed · 3 hit papers · h-index 11

Impact in

Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Oncology top 0.5%
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers

Papers in

Cancer Research 7
- Cancer Genomics and Diagnostics 7
Oncology 5

Co-authors: Chris Sander Nikolaus Schultz Anders J. Skanderup S. Onur Sumer Erik Larsson Jianjiong Gao Benjamin Groß Yichao Sun
Journals: Journal of Clinical Oncology (3 papers)Nature Communications (2 papers)BMC Bioinformatics (2 papers)Nucleic Acids Research (2 papers)The Journal of Urology (1 paper)
Partner nations: United States Germany France

In The Last Decade

Rileen Sinha

17 papers receiving 13.1k citations

Hit Papers

align trajectories log scale

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers 2016 · 862 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Journal of Clinical Investigation
2013 Nature Communications
2013 Science Signaling

Peers

Countries citing papers authored by Rileen Sinha

Since Specialization

Citations

This map shows the geographic impact of Rileen Sinha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rileen Sinha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rileen Sinha more than expected).

Fields of papers citing papers by Rileen Sinha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rileen Sinha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rileen Sinha. The network helps show where Rileen Sinha may publish in the future.

Co-authors

The 25 scholars most cited alongside Rileen Sinha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rileen Sinha Line = papers co-authored together Rileen Sinha links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Double Vision and Ventilatory Failure on Immunotherapy for Non-Small Cell Lung Cancer American Journal of Respiratory and Critical Care Medicine ·I. Castilla, Rileen Sinha, Richa Patel, Prabalini Rajendram, Stephen M. Pastores	2025	0
2	A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles Cell Reports Methods ·Rileen Sinha, Augustin Luna, Nikolaus Schultz, Chris Sander	2021	15
3	Association of a very high tumor mutational load with increased CD8+ and PD-1+ T-cell infiltration and improved clinical outcomes to PD-(L)1 blockade across different PD-L1 expression levels in non-small cell lung cancer. Journal of Clinical Oncology ·Biagio Ricciuti, Kathryn C. Arbour, Joao V. Alessi, Navin R. Mahadevan, James Lindsay, Rileen Sinha, Natalie I. Vokes, Gonzalo Recondo, Giuseppe Lamberti, Hira Rizvi, Giulia C. Leonardi, Andrew J. Plodkowski, Kristen D. Felt, Michael Tolstorukov, Pasi A. Jänne, Eliezer M. Van Allen, Lynette M. Sholl, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad	2021	2
4	Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection Nature Communications ·Rileen Sinha, Andrew Winer, Michael Chevinsky, Christopher Jakubowski, Ying‐Bei Chen, Yiyu Dong, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Jonathan Coleman, Chris Sander, James J. Hsieh, A. Ari Hakimi	2017	59
5	Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers Journal of Clinical Investigation ·Iñigo Landa, Tihana Ibrahimpašić, Laura Boucai, Rileen Sinha, Jeffrey A. Knauf, Ronak Shah, Snjezana Doğan, Julio C. Ricarte‐Filho, Gnana P. Krishnamoorthy, Bin Xu, Nikolaus Schultz, Michael F. Berger, Chris Sander, Barry S. Taylor, Ronald Ghossein, Ian Ganly, James A. Fagin Hit paper breakdown →	2016	862
6	Physiological state co-regulates thousands of mammalian mRNA splicing events at tandem splice sites and alternative exons Nucleic Acids Research ·Karol Szafranski, Veronicka Choubaeva, Frank Schumann, Piotr Wysocki, Rileen Sinha, Jochen Hampe, Michael Hiller, Christoph Englert, Klaus Huse, Matthias Platzer	2014	10
7	MP23-11 GENOMIC COMPARISON OF RENAL CELL CARCINOMA CELL LINES TO HUMAN TUMORS The Journal of Urology ·A. Ari Hakimi, Michael Chevinsky, James J. Hsieh, Chris Sander, Rileen Sinha	2014	5
8	Evaluating cell lines as tumour models by comparison of genomic profiles Nature Communications ·Silvia Domcke, Rileen Sinha, Douglas A. Levine, Chris Sander, Nikolaus Schultz Hit paper breakdown →	2013	1058
9	The molecular diversity of Luminal A breast tumors Breast Cancer Research and Treatment ·Giovanni Ciriello, Rileen Sinha, Katherine A. Hoadley, Anders J. Skanderup, Boris Reva, Charles M. Perou, Chris Sander, Nikolaus Schultz	2013	100
10	Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal Science Signaling ·Jianjiong Gao, Bülent Arman Aksoy, Uğur Doğrusöz, Gideon Dresdner, Benjamin Groß, S. Onur Sumer, Yichao Sun, Anders J. Skanderup, Rileen Sinha, Erik Larsson, Ethan Cerami, Chris Sander, Nikolaus Schultz Hit paper breakdown →	2013	10786
11	Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas Journal of Clinical Oncology ·Efsevia Vakiani, Manickam Janakiraman, Ronglai Shen, Rileen Sinha, Zhaoshi Zeng, Jinru Shia, Andrea Cercek, Nancy E. Kemeny, Michael I. D’Angelica, Agnès Viale, Adriana Heguy, Philip B. Paty, Timothy A. Chan, Leonard B. Saltz, Martin R. Weiser, David B. Solit	2012	215
12	The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: Impact on SHIP1/Ig-α interaction Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Safridatul ‘Audah, Lars Weingarten, Inken Padberg, Лаврентьева Алина, Rileen Sinha, Thomas Hochdörfer, Stephan Kuppig, Rolf Backofen, Michael Reth, Michael Huber	2011	14
13	Identification and characterization of NAGNAG alternative splicing in the moss Physcomitrella patens BMC Plant Biology ·Rileen Sinha, Andreas Zimmer, Kathrin Bolte, Daniel Lang, Ralf Reski, Matthias Platzer, Stefan A. Rensing, Rolf Backofen	2010	10
14	TassDB2 - A comprehensive database of subtle alternative splicing events BMC Bioinformatics ·Rileen Sinha, Thorsten Lenser, Niels Jahn, Ulrike Gausmann, Swetlana Friedel, Karol Szafranski, Klaus Huse, Philip Rosenstiel, Jochen Hampe, Stefan Schuster, Michael Hiller, Rolf Backofen, Matthias Platzer	2010	17
15	Accurate prediction of NAGNAG alternative splicing Nucleic Acids Research ·Rileen Sinha, Swetlana Nikolajewa, Karol Szafranski, Michael Hiller, Niels Jahn, Klaus Huse, Matthias Platzer, Rolf Backofen	2009	24
16	Assessing the fraction of short-distance tandem splice sites under purifying selection RNA ·Michael Hiller, Karol Szafranski, Rileen Sinha, Klaus Huse, Swetlana Nikolajewa, Philip Rosenstiel, Stefan Schreiber, Rolf Backofen, Matthias Platzer	2008	16
17	Improved identification of conserved cassette exons using Bayesian networks BMC Bioinformatics ·Rileen Sinha, Michael Hiller, Margherita De Cosmo, Ulrike Gausmann, Matthias Platzer, Rolf Backofen	2008	5
18	Prognostic significance of HER-2/neu over-expression on the incidence of brain metastasis in newly diagnosed breast cancer Journal of Clinical Oncology ·Bassam Abdulkarim, Zsolt Gabos, Rileen Sinha, Ray Van Wagoner, Hasan Abdollahzadeh, Judith Hugh, Audrey V. Sanzogni	2006	1

About Rileen Sinha

Rileen Sinha is a scholar working on Cancer Research, Oncology, Biophysics, Pathology and Forensic Medicine and Molecular Biology, having authored 18 papers that have together received 13.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), RNA Research and Splicing (5 papers), RNA and protein synthesis mechanisms (4 papers), RNA modifications and cancer (3 papers), Gene expression and cancer classification (3 papers), Genomics and Chromatin Dynamics (2 papers), Renal cell carcinoma treatment (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (4.2k citations), Oncology (4.3k citations), Molecular Biology (8.5k citations), Pulmonary and Respiratory Medicine (3.2k citations) and Pathology and Forensic Medicine (1.4k citations). Rileen Sinha has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Chris Sander, Nikolaus Schultz, Anders J. Skanderup, S. Onur Sumer, Erik Larsson, Jianjiong Gao, Benjamin Groß, Yichao Sun, Uğur Doğrusöz and Gideon Dresdner. Their work appears in journals such as Journal of Clinical Oncology, Nature Communications, BMC Bioinformatics, Nucleic Acids Research and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact